s6y
Company name or ticker
Search
CNS Pharmaceuticals, Inc.
4
Downs Christopher: Statement of changes in beneficial ownership of securities
Filed
Friday, March 31, 2023
Period
Mar 29, 2023
Accession number
0001683168-23-002095
Documents
ownership.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header